Treatment of aged skin with oral 13-cis-retinoic acid

Details Treatment of aged skin with oral 13-cis-retinoic acid Treatment of aged skin with oral 13-cis-retinoic acid

A - Human Necessities

61

K

167/263, 167/310

A61K 31/20 (2006.01) A61K 8/67 (2006.01) A61K 31/07 (2006.01)

Patent

CA 1326633

TREATMENT OF AGED SKIN WITH ORAL 13-CIS-RETINOIC ACID Abstract of the Invention Various disorders of the human skin, particularly facial skin, of elderly individuals, may be treated with low doses of 13-cis-retinoic acid by oral administration in amounts which are non-toxic and non-teratogenic. The disorders are those which appear in the elderly and are complicated by excessive sun exposure (photoaging), including sebaceous gland hyperplasia, follicular Demodex infestation, bacterial and fungi-induced folliculitis, rosacea-like and seborrheic-like dermatoses and dandruff-like scalp conditions. The treatment is effective at doses of as low as 1-5 mg daily or every other day, and is preferably used with women beyond childbearing potential, and males over about 50 years of age. The treatment also retards and reverses hyperkeratosis, epidermal atrophy, and other skin changes of the elderly.

563240

Affiliated with

Also associated with

Rating

Treatment of aged skin with oral 13-cis-retinoic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of aged skin with oral 13-cis-retinoic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of aged skin with oral 13-cis-retinoic acid will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1216317